Abstract
Abstract
Background
22q11.2 deletion syndrome (22q11.2DS) is a rare disease with an important characteristic—clinical heterogeneity. The diversity of organs, regions, and systems of the body that can be affected requires periodic updating of health professionals so that they can recognize these clinical signs as belonging to 22q11.2DS. Updated professionals are equally important for the appropriate and timely clinical management of individuals with a positive diagnosis. In this context, this article aimed to map and analyze the access to healthcare for individuals with 22q11.2DS until the moment of diagnosis.
Results
We analyzed the clinical data of 111 individuals with 22q11.2DS registered in the Brazilian Database on Craniofacial Anomalies (BDCA) from 2008 to 2020. In this study, individuals were diagnosed at a median age of 9 years (mean = 9.7 years). Before the genetic investigation, they accessed 68.75% of the internationally recommended evaluations available at BDCA. Recurrent 22q11.2DS clinical manifestations such as delayed neuropsychomotor development, lip and/or palate defects, cardiac malformation and/or hematological/immunological alteration co-occurred in at least 72.06% of individuals. Cardiac malformation was the only clinical alteration that lowered the median diagnostic age, corresponding to 6.5 years of age with a cardiac malformation versus 11 years of age without one (p = 0.0006).
Conclusions
In Brazil, 22q11.2 DS is under-recognized, and early diagnosis and management of affected individuals are still a distant reality. In this sense, 22q11.2 DS suspicion followed by the elimination of obstacles for its diagnosis confirmation is essential to increase life expectancy and improve the quality of life of these individuals in Brazil.
Funder
conselho nacional de desenvolvimento científico e tecnológico
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference36 articles.
1. Kruszka P, Addissie YA, Mcginn DE, Porras AR, Biggs E, Share M, et al. 22q11.2 Deletion syndrome in diverse populations HHS public access. Am J Med Genet A. 2017;173(4):879–88.
2. Digilio MC, Marino B, Capolino R, Dallapiccola B. Clinical manifestations of deletion 22q11.2 syndrome (DiGeorge / Velo- Cardio-Facial syndrome ) Congenital heart defects. Images Paediatr Cardiol. 2019;7(2):23–34.
3. Bassett AS, Mcdonald-mcginn DM, Devriendt K. Practical guidelines for managing patients with 22q11. 2011;159(2):1–17.
4. Fung WLA, Butcher NJ, Costain G, Andrade DM, Boot E, Chow EWC, et al. Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet Med. 2015;17(8):599–609.
5. Gil-da-Silva-Lopes V, Lustosa-Mendes E, Monteiro F. Guia de manejo clínico para pacientes com Síndrome de Deleção 22q11.2. Campinas; 2014. p. 1–29.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献